[{"Assets_0_FY_USD":367337000.0,"EarningsPerShareBasic_1_FY_USD":0.55,"EarningsPerShareBasic_4_FY_USD":1.25,"EarningsPerShareDiluted_1_FY_USD":0.5,"EarningsPerShareDiluted_4_FY_USD":1.17,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":141749000.0,"PaymentsOfDividendsCommonStock_4_FY_USD":281000.0,"StockholdersEquity_0_FY_USD":-242859000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":119866000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":106945000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180223"}]